nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.441	1	CbGbCtD
Salicylate-sodium—Acetylsalicylic acid—TP53—chronic obstructive pulmonary disease	0.00609	0.455	CrCbGaD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00464	0.0948	CbGpPWpGaD
Salicylate-sodium—Mesalazine—MPO—chronic obstructive pulmonary disease	0.00369	0.276	CrCbGaD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00369	0.0753	CbGpPWpGaD
Salicylate-sodium—PTGS2—leg—chronic obstructive pulmonary disease	0.00291	0.311	CbGeAlD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.00173	0.0354	CbGpPWpGaD
Salicylate-sodium—Magnesium salicylate—ALB—chronic obstructive pulmonary disease	0.00167	0.125	CrCbGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.00162	0.033	CbGpPWpGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.00138	0.0281	CbGpPWpGaD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.00136	0.0277	CbGpPWpGaD
Salicylate-sodium—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	0.00125	0.0255	CbGpPWpGaD
Salicylate-sodium—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00125	0.00256	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00124	0.00255	CcSEcCtD
Salicylate-sodium—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00124	0.00255	CcSEcCtD
Salicylate-sodium—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00123	0.00253	CcSEcCtD
Salicylate-sodium—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00253	CcSEcCtD
Salicylate-sodium—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00122	0.00251	CcSEcCtD
Salicylate-sodium—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00246	CcSEcCtD
Salicylate-sodium—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00246	CcSEcCtD
Salicylate-sodium—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.0012	0.00245	CcSEcCtD
Salicylate-sodium—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.00245	CcSEcCtD
Salicylate-sodium—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00119	0.00243	CcSEcCtD
Salicylate-sodium—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.00243	CcSEcCtD
Salicylate-sodium—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00243	CcSEcCtD
Salicylate-sodium—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00243	CcSEcCtD
Salicylate-sodium—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.00242	CcSEcCtD
Salicylate-sodium—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00117	0.00241	CcSEcCtD
Salicylate-sodium—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00117	0.0024	CcSEcCtD
Salicylate-sodium—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00116	0.00239	CcSEcCtD
Salicylate-sodium—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.00116	0.00238	CcSEcCtD
Salicylate-sodium—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00237	CcSEcCtD
Salicylate-sodium—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00235	CcSEcCtD
Salicylate-sodium—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00235	CcSEcCtD
Salicylate-sodium—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00233	CcSEcCtD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00113	0.0231	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.00113	0.023	CbGpPWpGaD
Salicylate-sodium—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00112	0.00229	CcSEcCtD
Salicylate-sodium—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00228	CcSEcCtD
Salicylate-sodium—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.0011	0.00227	CcSEcCtD
Salicylate-sodium—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00224	CcSEcCtD
Salicylate-sodium—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00223	CcSEcCtD
Salicylate-sodium—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00222	CcSEcCtD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.00108	0.022	CbGpPWpGaD
Salicylate-sodium—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00106	0.00218	CcSEcCtD
Salicylate-sodium—Acetylsalicylic acid—ALB—chronic obstructive pulmonary disease	0.00106	0.0793	CrCbGaD
Salicylate-sodium—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00104	0.00214	CcSEcCtD
Salicylate-sodium—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00212	CcSEcCtD
Salicylate-sodium—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00212	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00103	0.0021	CcSEcCtD
Salicylate-sodium—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00208	CcSEcCtD
Salicylate-sodium—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00101	0.00208	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00206	CcSEcCtD
Salicylate-sodium—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000999	0.00205	CcSEcCtD
Salicylate-sodium—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000996	0.00204	CcSEcCtD
Salicylate-sodium—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000996	0.00204	CcSEcCtD
Salicylate-sodium—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000996	0.00204	CcSEcCtD
Salicylate-sodium—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000992	0.00204	CcSEcCtD
Salicylate-sodium—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000992	0.00204	CcSEcCtD
Salicylate-sodium—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000992	0.00204	CcSEcCtD
Salicylate-sodium—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000991	0.00203	CcSEcCtD
Salicylate-sodium—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000991	0.00203	CcSEcCtD
Salicylate-sodium—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00099	0.00203	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.00098	0.02	CbGpPWpGaD
Salicylate-sodium—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000976	0.002	CcSEcCtD
Salicylate-sodium—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000972	0.00199	CcSEcCtD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000971	0.0198	CbGpPWpGaD
Salicylate-sodium—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000971	0.00199	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000967	0.00198	CcSEcCtD
Salicylate-sodium—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000962	0.00197	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000954	0.00196	CcSEcCtD
Salicylate-sodium—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000954	0.00196	CcSEcCtD
Salicylate-sodium—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000954	0.00196	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000954	0.00196	CcSEcCtD
Salicylate-sodium—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000952	0.00195	CcSEcCtD
Salicylate-sodium—Infection—Formoterol—chronic obstructive pulmonary disease	0.000948	0.00195	CcSEcCtD
Salicylate-sodium—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000948	0.00195	CcSEcCtD
Salicylate-sodium—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00094	0.00193	CcSEcCtD
Salicylate-sodium—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000939	0.00193	CcSEcCtD
Salicylate-sodium—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000937	0.00192	CcSEcCtD
Salicylate-sodium—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000935	0.00192	CcSEcCtD
Salicylate-sodium—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000935	0.00192	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000935	0.00192	CcSEcCtD
Salicylate-sodium—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000931	0.00191	CcSEcCtD
Salicylate-sodium—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000931	0.00191	CcSEcCtD
Salicylate-sodium—Infection—Montelukast—chronic obstructive pulmonary disease	0.000929	0.00191	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000924	0.0019	CcSEcCtD
Salicylate-sodium—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000915	0.00188	CcSEcCtD
Salicylate-sodium—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000914	0.00187	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000901	0.00185	CcSEcCtD
Salicylate-sodium—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000901	0.00185	CcSEcCtD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.000899	0.0184	CbGpPWpGaD
Salicylate-sodium—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000895	0.00184	CcSEcCtD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000895	0.0183	CbGpPWpGaD
Salicylate-sodium—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000892	0.00183	CcSEcCtD
Salicylate-sodium—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000892	0.00183	CcSEcCtD
Salicylate-sodium—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000887	0.00182	CcSEcCtD
Salicylate-sodium—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000887	0.00182	CcSEcCtD
Salicylate-sodium—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000885	0.00182	CcSEcCtD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000882	0.018	CbGpPWpGaD
Salicylate-sodium—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00088	0.00181	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MMP12—chronic obstructive pulmonary disease	0.000878	0.0179	CbGpPWpGaD
Salicylate-sodium—Salicylic acid—ALB—chronic obstructive pulmonary disease	0.000873	0.0653	CrCbGaD
Salicylate-sodium—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000871	0.00179	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000871	0.00179	CcSEcCtD
Salicylate-sodium—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000859	0.00176	CcSEcCtD
Salicylate-sodium—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000858	0.00176	CcSEcCtD
Salicylate-sodium—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000851	0.00175	CcSEcCtD
Salicylate-sodium—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000851	0.00175	CcSEcCtD
Salicylate-sodium—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000848	0.00174	CcSEcCtD
Salicylate-sodium—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000848	0.00174	CcSEcCtD
Salicylate-sodium—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000843	0.00173	CcSEcCtD
Salicylate-sodium—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000842	0.00173	CcSEcCtD
Salicylate-sodium—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00084	0.00172	CcSEcCtD
Salicylate-sodium—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00084	0.00172	CcSEcCtD
Salicylate-sodium—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000839	0.00172	CcSEcCtD
Salicylate-sodium—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000837	0.00172	CcSEcCtD
Salicylate-sodium—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000831	0.00171	CcSEcCtD
Salicylate-sodium—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000829	0.0017	CcSEcCtD
Salicylate-sodium—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000827	0.0017	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000824	0.0168	CbGpPWpGaD
Salicylate-sodium—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000823	0.00169	CcSEcCtD
Salicylate-sodium—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000823	0.00169	CcSEcCtD
Salicylate-sodium—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000823	0.00169	CcSEcCtD
Salicylate-sodium—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000816	0.00168	CcSEcCtD
Salicylate-sodium—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000816	0.00168	CcSEcCtD
Salicylate-sodium—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000816	0.00168	CcSEcCtD
Salicylate-sodium—Pain—Formoterol—chronic obstructive pulmonary disease	0.000816	0.00168	CcSEcCtD
Salicylate-sodium—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000809	0.00166	CcSEcCtD
Salicylate-sodium—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000806	0.00165	CcSEcCtD
Salicylate-sodium—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000803	0.00165	CcSEcCtD
Salicylate-sodium—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000801	0.00164	CcSEcCtD
Salicylate-sodium—Pain—Montelukast—chronic obstructive pulmonary disease	0.000799	0.00164	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000799	0.00164	CcSEcCtD
Salicylate-sodium—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000797	0.00164	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000794	0.00163	CcSEcCtD
Salicylate-sodium—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000793	0.00163	CcSEcCtD
Salicylate-sodium—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000791	0.00162	CcSEcCtD
Salicylate-sodium—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00079	0.00162	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000786	0.00161	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000786	0.00161	CcSEcCtD
Salicylate-sodium—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000786	0.00161	CcSEcCtD
Salicylate-sodium—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000783	0.00161	CcSEcCtD
Salicylate-sodium—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000782	0.00161	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00078	0.0016	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00078	0.0016	CcSEcCtD
Salicylate-sodium—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.00078	0.0016	CcSEcCtD
Salicylate-sodium—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000777	0.00159	CcSEcCtD
Salicylate-sodium—PTGS2—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000771	0.0157	CbGpPWpGaD
Salicylate-sodium—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000771	0.00158	CcSEcCtD
Salicylate-sodium—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000771	0.00158	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000764	0.00157	CcSEcCtD
Salicylate-sodium—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000758	0.00156	CcSEcCtD
Salicylate-sodium—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000758	0.00156	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000757	0.0155	CbGpPWpGaD
Salicylate-sodium—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000755	0.0808	CbGeAlD
Salicylate-sodium—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000754	0.00155	CcSEcCtD
Salicylate-sodium—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000754	0.00155	CcSEcCtD
Salicylate-sodium—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000754	0.00155	CcSEcCtD
Salicylate-sodium—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000754	0.00155	CcSEcCtD
Salicylate-sodium—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000752	0.00154	CcSEcCtD
Salicylate-sodium—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000746	0.00153	CcSEcCtD
Salicylate-sodium—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000745	0.00153	CcSEcCtD
Salicylate-sodium—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000745	0.00153	CcSEcCtD
Salicylate-sodium—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000743	0.00152	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000743	0.00152	CcSEcCtD
Salicylate-sodium—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000741	0.00152	CcSEcCtD
Salicylate-sodium—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000739	0.00152	CcSEcCtD
Salicylate-sodium—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000739	0.00152	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000737	0.00151	CcSEcCtD
Salicylate-sodium—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000729	0.0015	CcSEcCtD
Salicylate-sodium—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000722	0.0773	CbGeAlD
Salicylate-sodium—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000716	0.00147	CcSEcCtD
Salicylate-sodium—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000712	0.00146	CcSEcCtD
Salicylate-sodium—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000712	0.00146	CcSEcCtD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000706	0.0144	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000703	0.00144	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000703	0.00144	CcSEcCtD
Salicylate-sodium—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000702	0.00144	CcSEcCtD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000701	0.0143	CbGpPWpGaD
Salicylate-sodium—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000695	0.00143	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000689	0.00141	CcSEcCtD
Salicylate-sodium—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000685	0.00141	CcSEcCtD
Salicylate-sodium—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000685	0.00141	CcSEcCtD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00068	0.0139	CbGpPWpGaD
Salicylate-sodium—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000675	0.00139	CcSEcCtD
Salicylate-sodium—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000675	0.00139	CcSEcCtD
Salicylate-sodium—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000671	0.00138	CcSEcCtD
Salicylate-sodium—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000665	0.00136	CcSEcCtD
Salicylate-sodium—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000665	0.0711	CbGeAlD
Salicylate-sodium—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000664	0.00136	CcSEcCtD
Salicylate-sodium—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000661	0.00136	CcSEcCtD
Salicylate-sodium—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000653	0.00134	CcSEcCtD
Salicylate-sodium—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000653	0.00134	CcSEcCtD
Salicylate-sodium—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.000653	0.0133	CbGpPWpGaD
Salicylate-sodium—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00065	0.00133	CcSEcCtD
Salicylate-sodium—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000647	0.00133	CcSEcCtD
Salicylate-sodium—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000643	0.00132	CcSEcCtD
Salicylate-sodium—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00064	0.00131	CcSEcCtD
Salicylate-sodium—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000638	0.00131	CcSEcCtD
Salicylate-sodium—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000635	0.068	CbGeAlD
Salicylate-sodium—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000633	0.0013	CcSEcCtD
Salicylate-sodium—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000631	0.0013	CcSEcCtD
Salicylate-sodium—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000631	0.0013	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.000624	0.0127	CbGpPWpGaD
Salicylate-sodium—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000618	0.00127	CcSEcCtD
Salicylate-sodium—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000617	0.00127	CcSEcCtD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000614	0.0125	CbGpPWpGaD
Salicylate-sodium—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000608	0.0651	CbGeAlD
Salicylate-sodium—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000607	0.00125	CcSEcCtD
Salicylate-sodium—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000607	0.00125	CcSEcCtD
Salicylate-sodium—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.000603	0.0123	CbGpPWpGaD
Salicylate-sodium—Rash—Formoterol—chronic obstructive pulmonary disease	0.000602	0.00124	CcSEcCtD
Salicylate-sodium—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000602	0.00124	CcSEcCtD
Salicylate-sodium—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000601	0.00123	CcSEcCtD
Salicylate-sodium—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000601	0.00123	CcSEcCtD
Salicylate-sodium—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000601	0.00123	CcSEcCtD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000601	0.0123	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000599	0.0122	CbGpPWpGaD
Salicylate-sodium—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000598	0.00123	CcSEcCtD
Salicylate-sodium—Headache—Formoterol—chronic obstructive pulmonary disease	0.000598	0.00123	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000597	0.0122	CbGpPWpGaD
Salicylate-sodium—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000597	0.00123	CcSEcCtD
Salicylate-sodium—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000596	0.00122	CcSEcCtD
Salicylate-sodium—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000594	0.00122	CcSEcCtD
Salicylate-sodium—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000594	0.0636	CbGeAlD
Salicylate-sodium—Rash—Montelukast—chronic obstructive pulmonary disease	0.000589	0.00121	CcSEcCtD
Salicylate-sodium—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000589	0.00121	CcSEcCtD
Salicylate-sodium—Headache—Montelukast—chronic obstructive pulmonary disease	0.000586	0.0012	CcSEcCtD
Salicylate-sodium—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000581	0.0622	CbGeAlD
Salicylate-sodium—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000581	0.00119	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000577	0.00118	CcSEcCtD
Salicylate-sodium—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000573	0.00118	CcSEcCtD
Salicylate-sodium—PTGS2—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.000569	0.0116	CbGpPWpGaD
Salicylate-sodium—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000568	0.00117	CcSEcCtD
Salicylate-sodium—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000568	0.00117	CcSEcCtD
Salicylate-sodium—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000568	0.00117	CcSEcCtD
Salicylate-sodium—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000567	0.00116	CcSEcCtD
Salicylate-sodium—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000567	0.00116	CcSEcCtD
Salicylate-sodium—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000565	0.00116	CcSEcCtD
Salicylate-sodium—PTGS2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00056	0.0114	CbGpPWpGaD
Salicylate-sodium—PTGS1—trachea—chronic obstructive pulmonary disease	0.000558	0.0597	CbGeAlD
Salicylate-sodium—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000557	0.00114	CcSEcCtD
Salicylate-sodium—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000555	0.00114	CcSEcCtD
Salicylate-sodium—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000549	0.00113	CcSEcCtD
Salicylate-sodium—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000535	0.0011	CcSEcCtD
Salicylate-sodium—PTGS2—trachea—chronic obstructive pulmonary disease	0.000533	0.0571	CbGeAlD
Salicylate-sodium—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000526	0.00108	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000517	0.00106	CcSEcCtD
Salicylate-sodium—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000517	0.00106	CcSEcCtD
Salicylate-sodium—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000509	0.00104	CcSEcCtD
Salicylate-sodium—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000504	0.00104	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.0005	0.00103	CcSEcCtD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000496	0.0101	CbGpPWpGaD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000494	0.0101	CbGpPWpGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000488	0.00996	CbGpPWpGaD
Salicylate-sodium—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000472	0.000969	CcSEcCtD
Salicylate-sodium—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000464	0.000953	CcSEcCtD
Salicylate-sodium—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00046	0.000945	CcSEcCtD
Salicylate-sodium—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000442	0.000907	CcSEcCtD
Salicylate-sodium—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000435	0.00888	CbGpPWpGaD
Salicylate-sodium—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000434	0.00089	CcSEcCtD
Salicylate-sodium—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00043	0.00878	CbGpPWpGaD
Salicylate-sodium—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000426	0.000874	CcSEcCtD
Salicylate-sodium—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000413	0.000847	CcSEcCtD
Salicylate-sodium—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000411	0.000843	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000404	0.00083	CcSEcCtD
Salicylate-sodium—PTGS1—lung—chronic obstructive pulmonary disease	0.000401	0.0429	CbGeAlD
Salicylate-sodium—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000399	0.000818	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000398	0.00813	CbGpPWpGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000394	0.00804	CbGpPWpGaD
Salicylate-sodium—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00039	0.000801	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.00039	0.00797	CbGpPWpGaD
Salicylate-sodium—PTGS2—lung—chronic obstructive pulmonary disease	0.000383	0.041	CbGeAlD
Salicylate-sodium—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000381	0.000782	CcSEcCtD
Salicylate-sodium—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000376	0.000771	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000376	0.000771	CcSEcCtD
Salicylate-sodium—Infection—Prednisone—chronic obstructive pulmonary disease	0.000373	0.000766	CcSEcCtD
Salicylate-sodium—Shock—Prednisone—chronic obstructive pulmonary disease	0.00037	0.000758	CcSEcCtD
Salicylate-sodium—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000367	0.000752	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000363	0.000745	CcSEcCtD
Salicylate-sodium—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000361	0.00738	CbGpPWpGaD
Salicylate-sodium—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000358	0.000735	CcSEcCtD
Salicylate-sodium—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000342	0.000702	CcSEcCtD
Salicylate-sodium—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000337	0.000692	CcSEcCtD
Salicylate-sodium—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000331	0.000679	CcSEcCtD
Salicylate-sodium—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000327	0.00067	CcSEcCtD
Salicylate-sodium—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000326	0.000669	CcSEcCtD
Salicylate-sodium—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000326	0.000668	CcSEcCtD
Salicylate-sodium—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000324	0.000665	CcSEcCtD
Salicylate-sodium—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000324	0.000665	CcSEcCtD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.000323	0.0066	CbGpPWpGaD
Salicylate-sodium—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000321	0.000659	CcSEcCtD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000316	0.00646	CbGpPWpGaD
Salicylate-sodium—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00031	0.000635	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000307	0.00063	CcSEcCtD
Salicylate-sodium—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000307	0.00063	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000306	0.00624	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000306	0.00624	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000305	0.00623	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000301	0.00616	CbGpPWpGaD
Salicylate-sodium—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000298	0.000612	CcSEcCtD
Salicylate-sodium—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000297	0.000609	CcSEcCtD
Salicylate-sodium—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000297	0.000609	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.00028	0.00573	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000277	0.00566	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000277	0.000568	CcSEcCtD
Salicylate-sodium—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000269	0.000553	CcSEcCtD
Salicylate-sodium—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000266	0.000545	CcSEcCtD
Salicylate-sodium—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000264	0.00539	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000263	0.00536	CbGpPWpGaD
Salicylate-sodium—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000257	0.000527	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000252	0.00516	CbGpPWpGaD
Salicylate-sodium—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000248	0.00051	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000248	0.00507	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000245	0.005	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000243	0.00496	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000243	0.00496	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000242	0.00495	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.00024	0.00491	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.00024	0.00489	CbGpPWpGaD
Salicylate-sodium—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000239	0.00049	CcSEcCtD
Salicylate-sodium—Rash—Prednisone—chronic obstructive pulmonary disease	0.000237	0.000486	CcSEcCtD
Salicylate-sodium—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000237	0.000486	CcSEcCtD
Salicylate-sodium—Headache—Prednisone—chronic obstructive pulmonary disease	0.000235	0.000483	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.000228	0.00466	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	0.000225	0.00459	CbGpPWpGaD
Salicylate-sodium—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000223	0.000458	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000211	0.00432	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000197	0.00403	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.00018	0.00368	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000168	0.00343	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	0.000163	0.00332	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	0.000156	0.00318	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000151	0.00308	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	0.000147	0.003	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000145	0.00297	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000143	0.00292	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00014	0.00286	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000139	0.00283	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	0.000136	0.00278	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000127	0.00259	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	0.000121	0.00247	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.00012	0.00244	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	0.000119	0.00243	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000115	0.00236	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	0.000113	0.00231	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000111	0.00227	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00225	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	0.000108	0.00221	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.00206	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.0001	0.00205	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	9.97e-05	0.00204	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	9.13e-05	0.00186	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	8.98e-05	0.00183	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	8.24e-05	0.00168	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	8.08e-05	0.00165	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.01e-05	0.00164	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	7.7e-05	0.00157	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.44e-05	0.00152	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.35e-05	0.0015	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.85e-05	0.0014	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	6.79e-05	0.00139	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.71e-05	0.00137	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.18e-05	0.00126	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	5.93e-05	0.00121	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.9e-05	0.00121	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.84e-05	0.00119	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—KL—chronic obstructive pulmonary disease	5.51e-05	0.00113	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.44e-05	0.00111	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.33e-05	0.00109	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.15e-05	0.00105	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.08e-05	0.00104	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.91e-05	0.001	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.74e-05	0.000968	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.49e-05	0.000917	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	4.13e-05	0.000843	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.09e-05	0.000836	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.04e-05	0.000824	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.76e-05	0.000768	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.57e-05	0.000728	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	3.44e-05	0.000703	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	3.05e-05	0.000624	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.92e-05	0.000596	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	2.9e-05	0.000592	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	2.77e-05	0.000565	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	2.42e-05	0.000495	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.32e-05	0.000473	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	1.83e-05	0.000374	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	1.79e-05	0.000367	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	1.38e-05	0.000282	CbGpPWpGaD
